The Demand for Nanoparticles in Drug Formulation is Rising

11.02.2022

Demand for nanoparticles in the biopharmaceutical industry is on the rise. Production of these tiny particles, which can protect and deliver medicines and vaccines where they need to go in the body, has been increasing since 1989.

Collaborating with an experienced partner, such as a CDMO, could prove to be invaluable in developing nano-based systems.

Read more about the benefits and challenges of nanoparticle production.

Emergent CDMO

Thought Leadership Nanoparticles

03.22.2023

How to Mitigate Risk for Biologics During Fill/Finish Manufacturing

As more biologics move through research and development, the demand for specialized aseptic fill/finish services has steadily...

09.01.2020

All Hands on Deck for Fill/Finish of Vaccines and Therapeutics

“Emergent has a long, successful history of working with the US government to develop, manufacture, and deliver safe and...

05.27.2021

Supporting the Production of Next-Gen Therapies

“The Vanrx SA25 Aseptic Filling Workcell is a state-of-the-art machine, providing our clients with a high level of sterility...